Last week, members of the CureDRPLA team attended the International Congress for Ataxia Research (ICAR) 2026 in Atlanta, Georgia, the world’s largest conference dedicated to ataxia research. The meeting brought together around 600 researchers, clinicians, industry representatives and patient advocates from 29 countries, and featured more than 50 scientific presentations and over 260 research posters.
A special moment for our community was seeing Andrea Compton, co-founder of CureDRPLA, take part in the conference’s Living with Ataxia Patient Panel. Andrea represented the DRPLA community alongside advocates from other ataxia groups, sharing the experiences of individuals and families affected by this rare condition and helping bring the DRPLA perspective to this important discussion.
DRPLA research was also well represented throughout the meeting. Three posters from the global DRPLA Natural History and Biomarkers Study were presented at ICAR 2026. Two posters, led by Dr Hector Garcia-Moreno with senior author Prof Paola Giunti, focused on potential blood biomarkers for DRPLA and on demographic, clinical and genetic findings from study participants. A third poster, led by Dr Luis E. Almaguer-Mederos with senior author Prof. Henry Houlden, examined age- and tissue-dependent changes in the expanded ATN1 (Atrophin-1) gene repeat. Together, these studies are helping to build the foundations needed for supporting future clinical trial readiness and therapeutic development. Dr Martina Marconi and Prof. Paola Giunti presented these findings on behalf of the study teams at the conference.
Another DRPLA-focused poster presentation was delivered by Dr Joanna (“Asia”) Korecka from Mass General Brigham and Harvard Medical School, who is also a Scientific Advisor to CureDRPLA. Representing her research team, Asia presented work using stem-cell models to investigate the disease mechanisms that drive DRPLA and support the development of future therapeutic approaches.
The conference also included a presentation by Dr Hiroshi Adachi from University of Occupational and Environmental Health in Japan, who shared research comparing the clinical features and mobility milestones of people with juvenile- and adult-onset DRPLA.
Beyond the scientific programme, ICAR provided an opportunity to connect with researchers, clinicians, patient organisations and industry partners from across the international ataxia community. The range of DRPLA research presented in Atlanta, together with representation from both researchers and patient advocates, reflects the growing momentum behind efforts to better understand DRPLA and advance the development of effective treatments.
Image footnote: on top right Andrea Compton (second from left) participating in the Living with Ataxia Patient Panel. On bottom left Dr Julie Vallortigara, Prof Paola Giunti, Dr Martina Marconi and Dr Rosella Abeti. On bottom right Dr Joanna (“Asia”) Korecka, Dr Julie Greenfield and Dr Elisa Martelletti.

